scholarly article | Q13442814 |
P50 | author | Feiko ter Kuile | Q37606371 |
Din Syafruddin | Q42883393 | ||
Muhamad S. Dahlan | Q55180061 | ||
Ayleen Kosasih | Q55180062 | ||
Neil F Lobo | Q92416747 | ||
P2093 | author name string | Rita Kusriastuti | |
William A Hawley | |||
Inge Sutanto | |||
Sri Suprijanto | |||
P2860 | cites work | Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether | Q24792020 |
Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate | Q28469316 | ||
A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan | Q28471717 | ||
Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia | Q33263597 | ||
Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis | Q33489551 | ||
Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia | Q33530920 | ||
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals | Q33826283 | ||
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial | Q34164652 | ||
Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate-mefloquine treatment in Thailand | Q36868099 | ||
The role of anti-malarial drugs in eliminating malaria | Q37018629 | ||
Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria | Q37121012 | ||
Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations | Q37284075 | ||
Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. | Q39511728 | ||
Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria | Q39517554 | ||
Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes | Q41914713 | ||
In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs | Q41930870 | ||
Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum | Q41944750 | ||
Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum | Q44167789 | ||
Evidence for cyclic development and short-lived maturity in the gametocytes of Plasmodium falciparum | Q47956702 | ||
Effects of artemisinin derivatives on malaria transmissibility | Q48027455 | ||
PCR and strain identification in Plasmodium falciparum. | Q53860588 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Indonesia | Q252 |
malaria | Q12156 | ||
Plasmodium falciparum | Q311383 | ||
P304 | page(s) | 685-693 | |
P577 | publication date | 2012-11-21 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial | |
P478 | volume | 56 |
Q102371670 | A Novel Hybrid of Chloroquine and Primaquine Linked by Gold(I): Multitarget and Multiphase Antiplasmodial Agent |
Q41925849 | A Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection |
Q27014789 | Blocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysis |
Q36017687 | Combination therapy--a way to forestall artemisinin resistance and optimize uncomplicated malaria treatment |
Q37564052 | Community perceptions of targeted anti-malarial mass drug administrations in two provinces in Vietnam: a quantitative survey |
Q35150299 | Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan Africa |
Q24201077 | Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria |
Q43149117 | Editorial commentary: single-dose primaquine as gametocytocidal treatment in patients with uncomplicated falciparum malaria |
Q50107885 | Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial |
Q38399949 | Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance |
Q35860086 | Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy |
Q36290632 | In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparum |
Q34922792 | Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations. |
Q47860138 | Malaria and natural products: what is the future of this long-lasting relationship? |
Q37509562 | Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination |
Q36969682 | Nonrandomized controlled trial of artesunate plus sulfadoxine-pyrimethamine with or without primaquine for preventing posttreatment circulation of Plasmodium falciparum gametocytes |
Q36667896 | Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study |
Q43195189 | Potential of artemisinin-based combination therapies to block malaria transmission |
Q24193716 | Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission |
Q24188070 | Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission |
Q48024114 | Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission |
Q38904423 | Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial |
Q95266277 | Recurrence of Plasmodium malariae and P. falciparum Following Treatment of Uncomplicated Malaria in North Sumatera With Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine |
Q56352635 | Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis |
Q90369639 | Significant efficacy of single low dose primaquine compared to stand alone artemisinin combination therapy in reducing gametocyte carriage in Cambodian patients with uncomplicated multidrug resistant Plasmodium falciparum malaria |
Q34038938 | Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial |
Q33772980 | Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial |
Q37287860 | Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs. |
Q38245842 | Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination |
Q36730218 | Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda |
Q64246709 | The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial |
Q38673925 | Triple Combination Therapy and Drug Cycling-Tangential Strategies for Countering Artemisinin Resistance |
Search more.